The National Academies of Sciences, Engineering, and Medicine (NASEM) and the Royal Society have convened an international commission to develop a framework for considering technical, scientific, medical, regulatory, and ethical requirements for human germline genome editing, should society conclude such applications are acceptable.
To inform its deliberations, the Commission is engaging with external expertise and invites public comments. The call for evidence includes several questions that invite broad input; others are more technical in nature. It is being distributed to researchers and professional societies for genetic technologies and reproductive medicine, bioethics forums, patient community organizations, and others. Interested members of the public are also encouraged to participate.